Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration

Cyril Bouland 1, 2
Pierre Philippart 3, 4
Didier Dequanter 1, 3
Florent Corrillon 2
Isabelle Loeb 1, 3
Dominique Bron 3, 5
Laurence Lagneaux 2
Nathalie Meuleman 2, 3, 5
Publication typeJournal Article
Publication date2021-05-13
scimago Q1
wos Q1
SJR1.608
CiteScore11.4
Impact factor4.3
ISSN2296634X
Cell Biology
Developmental Biology
Abstract

Bone regeneration is a complex, well-orchestrated process based on the interactions between osteogenesis and angiogenesis, observed in both physiological and pathological situations. However, specific conditions (e.g., bone regeneration in large quantity, immunocompromised regenerative process) require additional support. Tissue engineering offers novel strategies. Bone regeneration requires a cell source, a matrix, growth factors and mechanical stimulation. Regenerative cells, endowed with proliferation and differentiation capacities, aim to recover, maintain, and improve bone functions. Vascularization is mandatory for bone formation, skeletal development, and different osseointegration processes. The latter delivers nutrients, growth factors, oxygen, minerals, etc. The development of mesenchymal stromal cells (MSCs) and endothelial progenitor cells (EPCs) cocultures has shown synergy between the two cell populations. The phenomena of osteogenesis and angiogenesis are intimately intertwined. Thus, cells of the endothelial line indirectly foster osteogenesis, and conversely, MSCs promote angiogenesis through different interaction mechanisms. In addition, various studies have highlighted the importance of the microenvironment via the release of extracellular vesicles (EVs). These EVs stimulate bone regeneration and angiogenesis. In this review, we describe (1) the phenomenon of bone regeneration by different sources of MSCs. We assess (2) the input of EPCs in coculture in bone regeneration and describe their contribution to the osteogenic potential of MSCs. We discuss (3) the interaction mechanisms between MSCs and EPCs in the context of osteogenesis: direct or indirect contact, production of growth factors, and the importance of the microenvironment via the release of EVs.

Found 
Found 

Top-30

Journals

1
2
3
4
International Journal of Molecular Sciences
4 publications, 8.51%
Frontiers in Cell and Developmental Biology
4 publications, 8.51%
Journal of Nanobiotechnology
2 publications, 4.26%
Biomolecules
2 publications, 4.26%
Biomaterials
2 publications, 4.26%
Bioengineering
1 publication, 2.13%
Pharmaceutics
1 publication, 2.13%
Journal of Biological Engineering
1 publication, 2.13%
Genes
1 publication, 2.13%
Aesthetic Plastic Surgery
1 publication, 2.13%
ACS applied materials & interfaces
1 publication, 2.13%
Chemical Engineering Journal
1 publication, 2.13%
iScience
1 publication, 2.13%
Bone Reports
1 publication, 2.13%
Cytokine
1 publication, 2.13%
Bone
1 publication, 2.13%
Cells
1 publication, 2.13%
Bioengineering & Translational Medicine
1 publication, 2.13%
BioMed Research International
1 publication, 2.13%
Cytotherapy
1 publication, 2.13%
Journal of Clinical Medicine
1 publication, 2.13%
FASEB Journal
1 publication, 2.13%
Tissue Engineering - Part C: Methods
1 publication, 2.13%
Biomimetics
1 publication, 2.13%
Cellular and Molecular Life Sciences
1 publication, 2.13%
Advanced Science
1 publication, 2.13%
Bioactive Materials
1 publication, 2.13%
Nanomedicine
1 publication, 2.13%
Frontiers in Pharmacology
1 publication, 2.13%
1
2
3
4

Publishers

2
4
6
8
10
12
MDPI
12 publications, 25.53%
Springer Nature
10 publications, 21.28%
Elsevier
10 publications, 21.28%
Frontiers Media S.A.
5 publications, 10.64%
Wiley
2 publications, 4.26%
American Chemical Society (ACS)
1 publication, 2.13%
Hindawi Limited
1 publication, 2.13%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 2.13%
Mary Ann Liebert
1 publication, 2.13%
Taylor & Francis
1 publication, 2.13%
SAGE
1 publication, 2.13%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 2.13%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
47
Share
Cite this
GOST |
Cite this
GOST Copy
Bouland C. et al. Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration // Frontiers in Cell and Developmental Biology. 2021. Vol. 9.
GOST all authors (up to 50) Copy
Bouland C., Philippart P., Dequanter D., Corrillon F., Loeb I., Bron D., Lagneaux L., Meuleman N. Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration // Frontiers in Cell and Developmental Biology. 2021. Vol. 9.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3389/fcell.2021.674084
UR - https://doi.org/10.3389/fcell.2021.674084
TI - Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration
T2 - Frontiers in Cell and Developmental Biology
AU - Bouland, Cyril
AU - Philippart, Pierre
AU - Dequanter, Didier
AU - Corrillon, Florent
AU - Loeb, Isabelle
AU - Bron, Dominique
AU - Lagneaux, Laurence
AU - Meuleman, Nathalie
PY - 2021
DA - 2021/05/13
PB - Frontiers Media S.A.
VL - 9
PMID - 34079804
SN - 2296-634X
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Bouland,
author = {Cyril Bouland and Pierre Philippart and Didier Dequanter and Florent Corrillon and Isabelle Loeb and Dominique Bron and Laurence Lagneaux and Nathalie Meuleman},
title = {Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration},
journal = {Frontiers in Cell and Developmental Biology},
year = {2021},
volume = {9},
publisher = {Frontiers Media S.A.},
month = {may},
url = {https://doi.org/10.3389/fcell.2021.674084},
doi = {10.3389/fcell.2021.674084}
}